Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

China in 2019: a prime destination for pharma R&D deals

Big pharma’s race for access to China’s pharma market has become bizarre at times; with displays of showmanship and cultural homage conducted alongside deals with and investment into the country. We take a look at trends that have marked 2019 as a big year for big pharma’s presence in China.

Close
Close
Close

Go Top